Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Evogene Reports Second Quarter and First Half 2026 Financial Results PR Newswire - Tue Aug 18, 7:04AM CDT

REHOVOT, Israel , Aug. 18, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules...

EVGN : 0.6011 (+3.18%)
Evogene: Q2 Earnings Snapshot AP - Tue Aug 18, 6:13AM CDT

Evogene: Q2 Earnings Snapshot

EVGN : 0.6011 (+3.18%)
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation PR Newswire - Fri Aug 14, 6:00AM CDT

Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET

EVGN : 0.6011 (+3.18%)
Evogene Schedules Second Quarter 2026 Financial Results Release PR Newswire - Thu Jul 30, 6:00AM CDT

Zoom conference call scheduled for August 18, 2026, 9:00 AM ET

EVGN : 0.6011 (+3.18%)
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases PR Newswire - Wed Jul 22, 7:00AM CDT

Collaboration combines Evogene's AI-driven computational chemistry platform with ELEO's proprietary biological capabilities to accelerate the discovery of novel oral therapies targeting a multi-billion-dollar...

EVGN : 0.6011 (+3.18%)
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities PR Newswire - Wed Jul 15, 6:30AM CDT

New AI model enables ChemPass AI for Ag™ to identify and prioritize antifungal molecules with a higher probability of biological success  at early discovery stages

EVGN : 0.6011 (+3.18%)
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery PR Newswire - Wed Jul 8, 6:00AM CDT

Supporting Israel's Academic Innovation Ecosystem: BCDD to Provide World-Class Experimental Infrastructure, Evogene to Deliver Computational Chemistry and AI Capabilities

EVGN : 0.6011 (+3.18%)
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization PR Newswire - Wed Jun 24, 7:00AM CDT

Integration of agentic computational systems enables the early-stage definition of key clinical and biological success criteria, accelerating discovery timelines, improving scalability, and increasing...

EVGN : 0.6011 (+3.18%)
Evogene to Present Its Pharma Division Achievements at the BIO International Convention PR Newswire - Tue Jun 9, 6:00AM CDT

Conference to be held in San Diego, CA, USA – June 22-25, 2026

EVGN : 0.6011 (+3.18%)
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica PR Newswire - Tue Jun 2, 6:00AM CDT

Study Results Demonstrated Favorable Safety Profile and Preliminary Signals of Clinical Activity

EVGN : 0.6011 (+3.18%)

Barchart Exclusives

Google Is Betting a Whopping $94 Billion on SpaceX Stock Barchart - 12 minutes ago
What does Google's $94 billion stake in SpaceX really mean? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.